Isoprinosine tablets 400 mg for subacute sclerosing panencephalitis

Are Isoprinosine tablets 400 mg effective for subacute sclerosing panencephalitis?

 

Isoprinosine tablets, containing the active ingredient inosine pranobex, offer a promising avenue in the treatment of subacute sclerosing panencephalitis (SSPE). These tablets function by bolstering the body's defense mechanisms and inhibiting the proliferation of viruses responsible for the disease, thereby mitigating its progression.

As an immunostimulant, Isoprinosine plays a pivotal role in augmenting the body's resistance to various diseases. For the subacute sclerosing panencephalitis, Isoprinosine tablets work as an analog of thymus hormones, orchestrating a robust immune response against the causative viruses.

Research and clinical trials have underscored the effectiveness of Isoprinosine in mitigating the symptoms of SSPE. For instance, in a comprehensive study titled "Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases," the positive impact of inosine pranobex on the immune system was highlighted. It was found to enhance the proliferation of T-cell lymphocytes, bolster the activity of natural killer cells, and elevate levels of pro-inflammatory cytokines. These effects collectively contribute to restoring deficient immune responses in individuals afflicted with SSPE.

In the case of sclerosing panencephalitis treatment, Isoprinosine tablets emerge as a promising therapeutic option. By harnessing the immunostimulatory properties of inosine pranobex, these tablets offer a viable strategy for impeding the progression of SSPE and ameliorating associated symptoms. With a foundation rooted in scientific validation and clinical evidence, Isoprinosine stands as a beacon of hope for individuals grappling with the challenges posed by subacute sclerosing panencephalitis.

 

Package details: 100 tablets

Dosage and administration: Take 50 to 100 milligrams per kilogram of body weight of the active ingredient, divided into 3 to 4 doses throughout the day. Your dosage might be tailored based on your age or specific symptoms. Each tablet of this medication contains 400 milligrams of the active ingredient. 

Active components: inosine pranobex

Therapeutic effect: subacute sclerosing panencephalitis

Contraindications and precautions: When administering to children, ensure they do not choke on the medicine. Regular laboratory tests are conducted to minimize the risk of adverse reactions. Do not expose to sunlight or heat. If allergic symptoms occur, discontinue use. Do not use in the following cases: